Home/Filings/4/0000899243-18-018327
4//SEC Filing

GV 2016 GP, L.L.C. 4

Accession 0000899243-18-018327

CIK 0001690585other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 4:28 PM ET

Size

15.5 KB

Accession

0000899243-18-018327

Insider Transaction Report

Form 4
Period: 2018-06-25
Transactions
  • Conversion

    Common Stock

    2018-06-25+3,339,1373,339,137 total(indirect: By GV 2016, L.P.)
  • Conversion

    Series B Preferred Stock

    2018-06-258,494,8640 total(indirect: By GV 2016, L.P.)
    Common Stock (3,287,511 underlying)
  • Conversion

    Series A Preferred Stock

    2018-06-25133,4000 total(indirect: By GV 2016, L.P.)
    Common Stock (51,626 underlying)
Alphabet Inc.
10% Owner
Transactions
  • Conversion

    Series A Preferred Stock

    2018-06-25133,4000 total(indirect: By GV 2016, L.P.)
    Common Stock (51,626 underlying)
  • Conversion

    Series B Preferred Stock

    2018-06-258,494,8640 total(indirect: By GV 2016, L.P.)
    Common Stock (3,287,511 underlying)
  • Conversion

    Common Stock

    2018-06-25+3,339,1373,339,137 total(indirect: By GV 2016, L.P.)
Transactions
  • Conversion

    Common Stock

    2018-06-25+3,339,1373,339,137 total(indirect: By GV 2016, L.P.)
  • Conversion

    Series B Preferred Stock

    2018-06-258,494,8640 total(indirect: By GV 2016, L.P.)
    Common Stock (3,287,511 underlying)
  • Conversion

    Series A Preferred Stock

    2018-06-25133,4000 total(indirect: By GV 2016, L.P.)
    Common Stock (51,626 underlying)
GV 2016, L.P.
10% Owner
Transactions
  • Conversion

    Common Stock

    2018-06-25+3,339,1373,339,137 total(indirect: By GV 2016, L.P.)
  • Conversion

    Series A Preferred Stock

    2018-06-25133,4000 total(indirect: By GV 2016, L.P.)
    Common Stock (51,626 underlying)
  • Conversion

    Series B Preferred Stock

    2018-06-258,494,8640 total(indirect: By GV 2016, L.P.)
    Common Stock (3,287,511 underlying)
Footnotes (2)
  • [F1]The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date.
  • [F2]The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001722201

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:28 PM ET
Size
15.5 KB